07 Feb 2019 (BioPharma-Reporter) -- RNAi research blooms with yeast-based production

Renaissance BioScience enters a partnership with Mitacs to test its yeast-based, RNAi production platform for biocontrol and biotherapeutics applications.

The University of British Columbia, Mitacs, and the University of Manitoba will join Renaissance BioScience Corporation (RBSC) in a three-year $975,000 CDN ($741,750), multi-investigator research and development project. 

Mitacs will provide matching funding for the RBSC project to extend its research and development of an engineered, yeast-based RNA interference (RNAi) production and delivery platform across insect and animal models.

Continue Reading

Back to all news